HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gamma-aminobutyric acid binds to GABAb receptor to inhibit cholangiocarcinoma cells growth via the JAK/STAT3 pathway.

AbstractBACKGROUND:
Gamma-aminobutyric acid (GABA) has been reported to inhibit the growth of cholangiocarcinoma QBC939 cells, but the mechanisms are still not fully understood.
AIMS:
To explore the mechanisms of the anti-cancer effect of GABA on QBC939 cells.
METHODS:
An initial immunohistochemistry study of the expressions of GABA receptors in cholangiocarcinoma tissues was followed by the culture and treatment of QBC939 cells for 48 h with GABA, GABA + bicuculine (GABAA receptor antagonist), GABA + phaclofen (GABAB receptor antagonist), and GABA + AG490 (Janus Kinase inhibitor). MTT and Annexin V-FITC/PI binding assays were used to determine the proliferation and apoptosis of the QBC939 cells. The expression of the signal transducer and activator of transcription 3 (STAT3) and phosphorylated STAT3 (Tyr705) [p-STAT3 (Tyr705)] was evaluated by the western blot assay. The effect of GABA on the growth of QBC939 xenograft tumors in athymic nu/nu mice was examined, and p-STAT3 (Tyr705) expression in xenograft tumors was detected by immunohistochemistry.
RESULTS:
A significant difference was only observed in GABAB receptor expression between cholangiocarcinoma and normal bile tissues. The MTT and Annexin V-FITC/PI assays showed that the antiproliferative and proapoptotic effects of GABA on QBC939 cells could be antagonized by phaclofen and AG490, but not bicuculine. GABA significantly down-regulated p-STAT3 (Tyr705) expression; this action was also antagonized by phaclofen and AG490. GABA also effectively inhibited xenograft tumor growth, and p-STAT3 (Tyr705) expression was significantly decreased in GABA-treated xenograft tumors.
CONCLUSIONS:
GABA may inhibit the growth of cholangiocarcinoma QBC939 cells through the GABAB receptor, and the anti-cancer effects may be partly mediated via the JAK/STAT3 pathway.
AuthorsQiang Huang, Cheng-Lin Zhu, Chen-Hai Liu, Fang Xie, Kai Zhu, San-Yuan Hu
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 58 Issue 3 Pg. 734-43 (Mar 2013) ISSN: 1573-2568 [Electronic] United States
PMID23007731 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, GABA-B
  • STAT3 Transcription Factor
  • gamma-Aminobutyric Acid
  • Janus Kinases
Topics
  • Animals
  • Cell Line, Tumor
  • Cholangiocarcinoma (metabolism, pathology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Janus Kinases (genetics, metabolism)
  • Mice
  • Mice, Nude
  • Neoplasms, Experimental (metabolism)
  • Protein Binding
  • Receptors, GABA-B (genetics, metabolism)
  • STAT3 Transcription Factor (genetics, metabolism)
  • gamma-Aminobutyric Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: